The effects of curcumin (diferuloylmethane) on body composition of patients with advanced pancreatic cancer.

Oncotarget · 2016 · PMC4991455 · PMID 26934122

Europe PMC DOI

hedged sentences

0.0540

closest p · 1.1× alpha

0.1300

boldest claim

The sentences

showed a trendp=0.054so close (0.05 < p ≤ 0.1)

At follow up, patients treated with curcumin showed a trend towards lower subcutaneous fat area at L3, total adipose area at L3 and total estimated body fat as compared to the patients in the control group (Table 2 , p=0.054, 0.07, and 0.07, respectively).

also in 53,322 other papers

did not reach statistical significancep=0.130not close (p > 0.1)

The average percent weight loss, while also greater in the treatment group (3.3% of the baseline weight versus 1.3% of the baseline weight for the control group), did not reach statistical significance (p=0.130).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.